Abnormalities of white and grey matter in early multiple system atrophy: comparison of parkinsonian and cerebellar variants.
Adult
Aged
Case-Control Studies
Cerebellum
/ diagnostic imaging
Diffusion Tensor Imaging
/ methods
Female
Gray Matter
/ diagnostic imaging
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Multiple System Atrophy
/ diagnostic imaging
Parkinsonian Disorders
/ diagnostic imaging
White Matter
/ diagnostic imaging
Cerebellum
Diffusion tensor imaging
Multiple system atrophy
Neuroimaging
Journal
European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
24
02
2018
accepted:
05
06
2018
revised:
21
05
2018
pubmed:
6
7
2018
medline:
26
2
2019
entrez:
6
7
2018
Statut:
ppublish
Résumé
Multiple system atrophy (MSA) is a neurodegenerative disorder with progressive motor and autonomic dysfunction. There is a paucity of information on the early neurostructural changes in MSA, especially its subtypes, MSA-P (patients with predominant parkinsonism) and MSA-C (patients with predominant cerebellar signs). This study investigates the abnormalities of grey matter (GM) and white matter (WM) in early MSA and its subtypes using multi-modal voxel-based analysis. Twenty-six patients with MSA with duration of symptoms ≤ 2.5 years (mean duration: 1.6 ±0.9 years) were assessed clinically and with 3T MRI. Voxel-based morphometry (VBM) and diffusion tensor imaging (DTI) were performed to identify the structural changes in MSA and its subtypes. The GM changes and diffusion parameters of WM tracts were correlated with the clinical scores. The results were compared with MRI of 25 age- and gender-matched healthy controls. The early structural changes in MSA included GM loss of the cerebellum and subcallosal gyrus with widespread involvement of supratentorial and infratentorial WM fibres. In MSA-C, GM loss was limited to the cerebellum with WM changes predominantly affecting the infratentorial WM and association tracts. In contrast, MSA-P did not demonstrate any GM loss and the WM involvement was mainly supratentorial. There was no significant correlation between structural changes and clinical severity score. In early MSA, WM microstructure was more affected than GM. These changes were greater in MSA-C than in MSA-P, suggesting variable deterioration in the subtypes of MSA. • Structural changes in early multiple system atrophy were evaluated using multi-modal neuroimaging. • White matter was more affected than grey matter in early MSA. • Clinical variables did not correlate with early structural changes.
Identifiants
pubmed: 29974222
doi: 10.1007/s00330-018-5594-9
pii: 10.1007/s00330-018-5594-9
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
716-724Références
J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):434-40
pubmed: 10727478
Neuroimage. 2005 Mar;25(1):287-93
pubmed: 15734363
Mov Disord. 2006 Feb;21(2):159-65
pubmed: 16161039
Mov Disord. 2006 Oct;21(10):1674-81
pubmed: 16830312
Neurology. 2006 Dec 26;67(12):2199-205
pubmed: 17190944
J Neurol. 2007 Feb;254(2):191-6
pubmed: 17334661
Neuroimage. 2007 Jul 15;36(4):1086-95
pubmed: 17512219
J Neuroimaging. 2009 Apr;19(2):127-31
pubmed: 18498329
Neurology. 2008 Aug 26;71(9):670-6
pubmed: 18725592
Neuroradiology. 2008 Nov;50(11):981-5
pubmed: 18779957
J Neuroimaging. 2010 Jul;20(3):260-6
pubmed: 19187475
Mov Disord. 2009 Apr 30;24(6):863-70
pubmed: 19194988
Mov Disord. 2009 May 15;24(7):949-64
pubmed: 19306362
Eur J Neurol. 2009 Oct;16(10):1144-50
pubmed: 19486137
Lancet Neurol. 2009 Dec;8(12):1172-8
pubmed: 19909915
Med Image Anal. 2010 Apr;14(2):205-18
pubmed: 20005152
Radiology. 2010 May;255(2):563-9
pubmed: 20413765
J Magn Reson Imaging. 2010 Jul;32(1):69-75
pubmed: 20578012
Mov Disord. 2010 Nov 15;25(15):2613-20
pubmed: 20623690
Neuroradiology. 2011 Jul;53(7):471-81
pubmed: 20737142
Trends Neurosci. 2011 Nov;34(11):581-90
pubmed: 21962754
Neuroimage. 2012 Jul 16;61(4):1484-94
pubmed: 22484407
Lancet Neurol. 2013 Mar;12(3):264-74
pubmed: 23391524
Parkinsonism Relat Disord. 2013 Jun;19(6):617-21
pubmed: 23529023
Neuroimage Clin. 2013 Apr 05;2:491-6
pubmed: 24179801
J Neural Transm (Vienna). 2014 May;121(5):507-12
pubmed: 24337696
Int J Neurosci. 2015 Jan;125(1):18-24
pubmed: 24555517
Parkinsonism Relat Disord. 2014 Oct;20(10):1050-5
pubmed: 25037563
PLoS One. 2014 Nov 18;9(11):e112638
pubmed: 25405990
N Engl J Med. 2015 Jan 15;372(3):249-63
pubmed: 25587949
J Neurol Neurosurg Psychiatry. 2016 Apr;87(4):443-4
pubmed: 25699570
Lancet Neurol. 2015 Jul;14(7):710-9
pubmed: 26025783
Neurodegener Dis. 2015;15(5):294-300
pubmed: 26202063
Eur J Neurol. 2016 Jan;23(1):92-100
pubmed: 26234320
Neuropsychiatr Dis Treat. 2016 Aug 26;12:2181-7
pubmed: 27616888
Acta Neurol Belg. 2017 Mar;117(1):213-220
pubmed: 27878764
Parkinsonism Relat Disord. 2017 Jun;39:44-51
pubmed: 28291592
Curr Neurol Neurosci Rep. 2017 May;17(5):41
pubmed: 28378233